Owner AstraZeneca AB

Inventors Waring, Michael James; Stokes, Elaine Sophie Elizabeth; Roberts, Craig Anthony

Agent Davies Collison Cave

Pub. Number AU-B-2003217054

PCT Number PCT/GB03/01442

PCT Pub. Number WO2003/087057

Priority 0207863.2 05.04.02 GB; 0229930.3 21.12.02 GB

Filing date 2 April 2003

Wipo publication date 27 October 2003

Acceptance publication date 29 January 2009

C07D 251/14 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4365 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/444 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/4525 (2006.01)

A61K 31/453 (2006.01)

A61K 31/454 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/497 (2006.01)

A61K 31/505 - Pyrimidines